跳至主要内容
临床试验/NCT02512354
NCT02512354已完成不适用

Contribution of High-throughput Exome Sequencing in Fetopathology

Centre Hospitalier Universitaire Dijon10 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2015年3月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
10
主要终点
Number of diagnoses not made by HTES compared with usual examinations

研究概览

简要总结

This research concerns the contribution of a new examination, high-throughput exome sequencing, in the diagnosis of the cause of polymalformative fetal syndromes. With currently available examinations, the causes of polyformative syndromes, which correspond to the association of several congenital malformations with varying degrees of severity in different organs, remain unknown in a large number of cases.

High-throughput exome sequencing (HTES) is a diagnostic tool that allows the simultaneous analysis of all of the coding parts of DNA. This examination has already shown its superior diagnostic capability in every post-natal diagnostic context, in particulier in infants with malformations associated or not with intellectual deficiency. Its contribution has not yet been studied in a large number of fetuses with polymalformations. To investigate the usefulness of HTES, we propose to carry out the examination in 100 fetuses with polymalformations, as well as the usual examinations including chromosomal microarray analysis and possibly the study of specific genes that may explain these malformations. A blood sample will be taken from both parents to allow interpretation of the results.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Fetus with at least 2 malformations, with no diagnosis (or several low-certainty diagnostic hypotheses, which require several molecular examinations) after fetopathological and radiological examinations
  • Written consent from both parents
  • Possibility to obtain samples from both parents

排除标准

  • Refusal of parents to take part in the study
  • Parents without National Health Insurance cover
  • Parents under guardianship or in custody
  • Impossibility to obtain samples from both parents
  • Diagnostic hypothesis considered highly probable for which a molecular test cheaper that HTES is available

研究组 & 干预措施

Fetus

干预措施: Sample of a fragment of fetal tissue (Other)

Fetus

干预措施: Parent's blood samples (Other)

结局指标

主要结局

Number of diagnoses not made by HTES compared with usual examinations

时间窗: baseline

Number of additional diagnoses made thanks to HTES compared with the usual examinations

时间窗: baseline

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验